• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Paysign Inc.

    3/26/26 7:34:40 AM ET
    $PAYS
    EDP Services
    Technology
    Get the next $PAYS alert in real time by email
    DEFA14A 1 paysign_defa14a.htm ADDITIONAL MATERIALS

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    ________________

     

    SCHEDULE 14A

    (Rule 14a-101)
    ________________

     

    INFORMATION REQUIRED IN PROXY STATEMENT
    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of the Securities
    Exchange Act of 1934 (Amendment No. _____)

     

     

    Filed by the Registrant   ☒
    Filed by a Party other than the Registrant   ☐

     

    Check the appropriate box:

     

    ☐   Preliminary Proxy Statement
    ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐   Definitive Proxy Statement
    ☒   Definitive Additional Materials
    ☐   Soliciting Material Pursuant to §240.14a-12

     

     

    Paysign, Inc.

     

    (Name of Registrant as Specified in its Charter)

     

     

     

    (Name of Person(s) Filing Proxy Statement if other than the Registrant)

     

     

    Payment of Filing Fee (Check all boxes that apply):

     

    ☒   No fee required
    ☐   Fee paid previously with preliminary materials
    ☐  

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     

     

     

     

     

     

     

       

     

     

     

    PAYSIGN, INC.  

    CONTROL ID:  
    REQUEST ID:  
     

    IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
    for the Annual Meeting of Stockholders

     

      DATE: May 8, 2026
      TIME: 4:00 p.m. Pacific Daylight Time
      LOCATION: M Resort spa casino, 12300 las vegas blvd. s, henderson, Nevada 89044
         

     

    HOW TO REQUEST PAPER COPIES OF OUR MATERIALS

     

           

    PHONE:

    Call toll free
    1-866-752-8683

    FAX:

    Send this card to
    202-521-3464

    INTERNET:
    https://www.iproxydirect.com/pays
    and follow the on-screen instructions.

    EMAIL:

    [email protected]
    Include your Control ID in your email.

     

     

    This communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is available at: https://www.iproxydirect.com/pays

     
    If you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy.  To facilitate timely delivery please make the request, as instructed above, before April 16, 2026
     
    you may enter your voting instructions at https://www.iproxydirect.com/pays
    until 11:59 pm eastern time May 7, 2026.
     
     

    The purposes of this meeting are as follows:

     

     
     

    1.     To elect to the Board of Directors the seven nominees for director named in the proxy statement, to hold office until the 2027 annual meeting of our stockholders;

    2.     To ratify the selection of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and

    3.     To conduct any other business properly brought before the meeting.

     

     

     

    Pursuant to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the 2026 Annual Meeting are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies.

     

    The board of directors has fixed the close of business on March 9, 2026 as the record date for the determination of stockholders entitled to receive notice of the 2026 Annual Meeting and to vote the shares of our common stock, par value $0.001 per share, they held on that date at the meeting or any postponement or adjournment of the meeting.

     

    The Board of Directors recommends that you vote “for” all of the director nominees; “for” the ratification of the selection of Baker Tilly US, LLP as our independent registered public accounting firm to audit the financial statements for the fiscal year ending December 31, 2026; and as to any other business that may come before the 2026 Annual Meeting.

     
    Please note - This is not a Proxy Card - you cannot vote by returning this card
                   

     

     

     2 

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Paysign, Inc.

    SHAREHOLDER SERVICES

    1 Glenwood Avenue Suite 1001

    Raleigh NC 27603

     

    FIRST-CLASS MAIL

    US POSTAGE

    PAID

    RALEIGH NC

    PERMIT # 870

     

     

     

     

    Time Sensitive shareholder information enclosed

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    IMPORTANT SHAREHOLDER INFORMATION

     

    your vote is important

     

     

     

     

     

     

     

     

     

     3 

     

    Get the next $PAYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Baker Jeffery Bradford covered exercise/tax liability with 26,055 shares and converted options into 60,000 shares, increasing direct ownership by 10% to 386,218 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    3/2/26 4:02:34 PM ET
    $PAYS
    EDP Services
    Technology

    Chief Legal Officer Strobo Robert sold $109,400 worth of shares (20,000 units at $5.47), decreasing direct ownership by 6% to 327,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    12/12/25 6:08:20 PM ET
    $PAYS
    EDP Services
    Technology

    Chief Legal Officer Strobo Robert was granted 100,000 shares, increasing direct ownership by 40% to 347,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:46 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

    Mix Shift Drives Gross and Operating Margin Expansion Strong Balance Sheet Enables Continued Investment for Profitable Growth Paysign, Inc. (NASDAQ:PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the fourth quarter and full-year 2025. Full-Year Financial Highlights Full-year 2025 total revenues of $82.0 million, up 40.5% from 2024 Total net plasma center count increased by 115 during 2025, exiting the year with 595 centers, contributing to a 4.0% increase in plasma revenue versus the same period

    3/24/26 4:10:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss fourth quarter and full year 2025 earnings at 5:00 p.m. Eastern time on Tuesday, March 24, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13758162 The replay will be available until June 24, 2026. To register as a financial professional in order to ask questions during the call, please email [email protected] no later

    2/24/26 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format. The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign's Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3. Investors interested in registering may contact their Oppe

    1/21/26 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    6/16/25 9:00:04 PM ET
    $PAYS
    EDP Services
    Technology

    Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/28/25 8:07:31 PM ET
    $PAYS
    EDP Services
    Technology

    Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/15/24 6:19:59 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    SEC Filings

    View All

    SEC Form DEFA14A filed by Paysign Inc.

    DEFA14A - Paysign, Inc. (0001496443) (Filer)

    3/26/26 7:34:40 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form DEF 14A filed by Paysign Inc.

    DEF 14A - Paysign, Inc. (0001496443) (Filer)

    3/26/26 7:33:40 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form 10-K filed by Paysign Inc.

    10-K - Paysign, Inc. (0001496443) (Filer)

    3/25/26 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PaySign with a new price target

    Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

    12/20/24 8:45:02 AM ET
    $PAYS
    EDP Services
    Technology

    Barrington Research initiated coverage on PaySign with a new price target

    Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

    3/30/22 8:15:53 AM ET
    $PAYS
    EDP Services
    Technology

    PaySign downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded PaySign from Buy to Neutral

    3/24/22 7:30:30 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Financials

    Live finance-specific insights

    View All

    Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

    Mix Shift Drives Gross and Operating Margin Expansion Strong Balance Sheet Enables Continued Investment for Profitable Growth Paysign, Inc. (NASDAQ:PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the fourth quarter and full-year 2025. Full-Year Financial Highlights Full-year 2025 total revenues of $82.0 million, up 40.5% from 2024 Total net plasma center count increased by 115 during 2025, exiting the year with 595 centers, contributing to a 4.0% increase in plasma revenue versus the same period

    3/24/26 4:10:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports Third Quarter 2025 Financial Results

    Delivered strong performance with record revenue and improved profitability Third quarter 2025 total revenues of $21.60 million, up 41.6% from third quarter 2024 Third quarter 2025 net income of $2.22 million, up 54.2% from $1.44 million a year ago, while diluted earnings per share was $0.04 versus $0.03 for third quarter 2024 Third quarter 2025 Adjusted EBITDA of $5.04 million (23.3% of revenues), up 78.1% from $2.83 million (18.5% of revenues) a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.05 for third quarter 20241 Year-over-year plasma revenue increased 12.4% to $12.86 million; exited the quarter with 595 plasma centers, an increase of 117 plasma ce

    11/12/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Paysign Inc.

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    11/14/24 7:00:30 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    2/12/24 12:36:58 PM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    1/24/24 4:05:27 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Leadership Updates

    Live Leadership Updates

    View All

    Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

    Garcia Tapped to Lead Strategy for Company's Life Science Solutions Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions. In his new role at Paysign, Mr. Garcia will implement and execute the market strategy for the company's comprehensive suite of engagement and management solutions targeting the life sciences industries. With more than two decades of executive experience in life sciences services, Mr. Garcia is a

    9/22/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

    Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

    3/25/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology